Official UK procurement notice
Helix Biotech Biosimilar mRNA Vaccines
Authority: Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency (Central government)
Sectors: Medical Devices & Pharma (33) Delivery: Delivery location not published
Budget not disclosedValue not published
Submission deadline Not published
What is being bought
Published requirement descriptionVaccine mimic materials-comprising messenger RNA (mRNA) and lipid nanoparticles (LNPs)-from Helix-Biotech.
The lotProcurement structure
single lot · no lot value publishedLot #1Lot 1Awarded
33651600 Vaccines
Procedure terms & legal framework
From the official record- Procedure method
- Direct award
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Notice status
- Cancelled
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- No (one-off requirement)
- First published
- 4 Sept 2025, 13:41 BST
- Last source update
- 4 Sept 2025, 13:41 BST
- Authority reference
C371747- Latest notice
- Procurement termination notice (UK12)
- Delivery area
- Not published
- Official registry OCID
ocds-h6vhtk-0585bd
- Why no open competition
- Single Suppliers Technical Reasons
- Published justification
- Helix-Biotech Inc. is the only supplier capable of delivering the required vaccine mimic materials (mRNA encapsulated in LNPs) with validated equivalence to licensed Pfizer-style COVID-19 vaccines. Their proprietary methodology and formulation capability are not available from other suppliers, nor covered under any current public procurement frameworks.
Review and risk notes
- Risks
- A valid and current Cyber Essentials Certificate is required.
Commercial outcome & contract awards
Published awards, contracts and bid statistics — not a forecastAwards 1
| Awarded to | Value | Date | Status |
|---|---|---|---|
| Helix Biotech Inc.8 Sept 2025 — 7 Sept 2027 | £150,000 | 2 Sept 2025 | CancelledWe are currently unable to modify the description on the Transparency Notice and therefore a termination notice has been issued for this procedure and a new UK5 Transparency Notice will be published with a modified description. |
Notice history
6 events · 2 releases on Find a Tender · since 12 Aug 2025- Procurement termination notice published4 Sept 2025, 13:41 BSTUK12
- Status changed4 Sept 2025, 13:41 BST
- Procurement method changed4 Sept 2025, 13:41 BST
- Buyer details updated4 Sept 2025, 13:41 BST
- Contract signature expected1 Sept 2025, 23:59 BSTscheduled
- Transparency notice published12 Aug 2025, 10:18 BSTUK5
Contracting authority & participating public bodies
Bidders & participating suppliers
1 commercial party on the notice- Helix Biotech, Inc.Awarded supplier
Official documents & specifications (3)
Official links; attachments are not copiedTender pack and attachments
- Conflict of interest declarationNot published
Notices published for this procedure
- Procurement termination notice Procurement termination notice on Find a Tender
- Transparency notice Transparency notice on Find a Tender